Administration of Myelin Basic Protein Peptides Encapsulated in Mannosylated Liposomes Normalizes Level of Serum TNF-α and IL-2 and Chemoattractants CCL2 and CCL4 in Multiple Sclerosis Patients

Figure 2

The Th1/Th2 serum ratio in the treatment group at the time of the screening (−2 weeks), 7, 10, and 18 weeks. The interquartile range is shown by boxes. The median in each group is shown by the bold line. Bars represent 95% confidence interval. Statistically significant differences with their respective values are indicated.